CJC-1295 with DAC

Most Common Uses

CJC-1295 with DAC is primarily used in research settings to evaluate its effectiveness in stimulating the pituitary gland to release growth hormone (GH). By binding to albumin through the Drug Affinity Complex (DAC), it extends the half-life of the peptide, allowing for more sustained GH release. This prolonged exposure to elevated GH levels is central to the peptide’s research value, especially in studies exploring hormonal regulation and metabolic health.

Promotion of Lean Muscle Mass and Fat Reduction

Increased growth hormone and IGF-1 levels are associated with improved body composition. Research has focused on how CJC-1295 with DAC may promote anabolic processes, such as protein synthesis and nitrogen retention, which are key for lean muscle development. Simultaneously, GH is known to stimulate lipolysis, the breakdown of fat stores for energy, suggesting potential applications in fat reduction and metabolic efficiency.

By enhancing protein synthesis and satellite cell activation, IGF-1 aids muscle repair and regeneration, which proves beneficial during recovery from intense physical activity. This involves satellite cells proliferating and fusing with existing muscle fibers to repair damage and promote growth. GH also increases collagen synthesis, strengthens connective tissues, and reduces injury risk during training, which supports long-term muscle development.

Recovery from Training or Injury

GH and IGF-1 are important for tissue repair and regeneration. Studies on CJC-1295 with DAC have investigated its role in accelerating recovery from physical training or soft tissue injuries. Increased GH levels can support muscle fiber repair, reduce inflammation, and aid in the regeneration of connective tissues, making this peptide of interest in sports medicine and rehabilitation research.

Collagen Synthesis and Skin Elasticity

Collagen production declines with age, contributing to skin thinning and reduced elasticity. Growth hormone has been linked to increased collagen synthesis in the dermis. Research involving CJC-1295 with DAC explores whether its ability to boost GH levels can support skin health by enhancing firmness, hydration, and reducing the appearance of fine lines over time.

The mechanism by which GH supports collagen synthesis involves signaling pathways that activate fibroblast proliferation and extracellular matrix production. Increased GH levels can enhance the expression of transforming growth factor-beta (TGF-β), a cytokine that stimulates collagen and elastin formation, contributing to a thicker, more resilient dermal layer. Research suggests that CJC-1295 with DAC’s ability to maintain higher GH levels may also improve skin hydration by supporting the production of glycosaminoglycans, such as hyaluronic acid, which retain water in the skin.

Energy, Libido, and Well-Being

Growth hormone (GH) plays a significant role in regulating mood, energy levels, and sexual health, contributing to an overall sense of vitality. Research on CJC-1295 with DAC, a growth hormone-releasing hormone (GHRH) analog, has explored its ability to increase GH levels, with studies noting improvements in energy, libido, and general well-being, particularly in individuals with lower baseline GH levels. By extending the half-life of GHRH, CJC-1295 with DAC promotes sustained GH release, which may enhance physiological resilience and hormonal balance.

The effects of GH on energy and well-being are tied to its role in optimizing mitochondrial function and glucose metabolism, which provide cells with the energy needed for daily activities. Increased GH levels may boost the production of ATP, the body’s primary energy currency, leading to greater stamina and reduced fatigue.

Libido improvements observed with CJC-1295 with DAC likely stem from GH’s influence on testosterone production and vascular health. GH can stimulate the hypothalamic-pituitary-gonadal axis, indirectly supporting sex hormone levels, which are critical for sexual desire and performance. Improved blood flow, driven by GH’s effects on nitric oxide production, may also enhance erectile function and sexual responsiveness. These benefits are particularly pronounced in individuals with age-related GH declines, where hormonal imbalances often contribute to reduced libido.

Potential Anti-Aging Applications

As natural GH levels decline with age, researchers have explored CJC-1295 with DAC for its possible anti-aging effects. Studies are examining its ability to restore more youthful GH profiles in older populations, which may be linked to improvements in body composition, skin quality, recovery, and overall vitality. These investigations aim to better understand how GH modulation can influence aging biomarkers and age-related decline.

Warnings and Cautions

CJC-1295 with DAC is generally well tolerated in research, but potential side effects may include water retention, tingling or numbness in extremities, joint pain, or flu-like symptoms. It should not be used by individuals with active cancer due to GH’s potential to accelerate tumor growth.

This compound is intended for research purposes only and is not approved for human use outside of clinical studies. Counterfeit products in unregulated markets may pose additional safety concerns.

Dosages

Dosages in research are individualized and typically administered via subcutaneous injection. Common protocols include:

• 100 mcg per injection, 2 times per week.
• Cycling regimens (e.g., 8-12 weeks on, 4 weeks off) to prevent desensitization.
• Often dosed at bedtime to align with natural GH pulses.

Dosing should be tailored to research goals and subject response, with careful monitoring.

Mechanism of Action

CJC-1295 with DAC works by mimicking the body’s natural growth hormone–releasing hormone (GHRH). It binds to specific receptors in the pituitary gland, triggering the release of growth hormone (GH) in pulses, much like how the body normally produces it. This pattern of release helps keep the body’s hormone signaling in balance and supports normal physiological responses.

What sets CJC-1295 with DAC apart is the DAC component—a chemical structure that allows the peptide to attach to a protein in the blood called albumin. This connection helps protect the peptide from being broken down too quickly, giving it a much longer duration of action. While natural GHRH is cleared from the body in minutes, CJC-1295 with DAC can stay active for nearly a week, making it useful in studies that aim to maintain more consistent GH levels over time.

The increase in GH also leads to more production of insulin-like growth factor 1 (IGF-1), mainly in the liver. IGF-1 plays a key role in cell growth, muscle building, and tissue repair. Together, GH and IGF-1 support protein production, help the body burn fat for energy, and assist in healing after physical stress or injury.

Structure and Pharmacology

CJC-1295 with DAC is a 30-amino-acid peptide with a modified sequence to resist enzymatic breakdown. Its structure includes D-amino acids for stability, and the DAC conjugate enhances plasma retention. The base molecular formula is C152H252N44O42, with a molecular weight of ~3,647.09 g/mol (without DAC).

Pharmacologically, it shows high receptor affinity and low toxicity in research models. It remains stable when lyophilized and stored at 2-8°C, reconstituted with bacteriostatic water for injection. Subcutaneous administration yields near-100% bioavailability, with peak GH levels within hours.

History

CJC-1295 with DAC was developed in the early 2000s by ConjuChem, a biotechnology company based in Canada. The goal was to create a long-acting version of growth hormone–releasing hormone (GHRH) that could stimulate the body’s own production of growth hormone with less frequent dosing. The key innovation was the Drug Affinity Complex (DAC), a molecular attachment that allows the peptide to bind to albumin in the bloodstream. This significantly extended its half-life compared to natural GHRH, which is rapidly broken down in the body.

Initial research focused on using CJC-1295 with DAC to treat growth hormone deficiency and related metabolic disorders. Early clinical trials showed promise in increasing growth hormone and IGF-1 levels over an extended period, but regulatory challenges and limited commercial success led to a shift away from therapeutic development. As a result, the compound found its primary role in the research community, where it remains under investigation for its effects on hormone regulation, metabolism, and tissue repair.